TWENTY LARGEST PUBLIC ANTITRUST LAW TRANSACTIONS
No.
|
TRANSACTION SCOPE
|
AMOUNT
|
LAW FIRMS ACCOMPANYING THE TRANSACTIONS |
1
|
Obtaining new merger clearances from the Antimonopoly Committee of Ukraine for The Dow Chemical Company and E.I. du Pont de Nemours and Company
|
about 130 bln USD
|
Asters for and on behalf of The Dow Chemical Company. Sayenko Kharenko, Skadden for and on behalf of E.I. du Pont de Nemours and Company |
2
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine for acquisition of a controlling interest in Monsanto Company by Bayer Aktiengesellschaft
|
about 66 bln USD
|
Asters for and on behalf of Bayer Aktiengesellschaft. Baker McKenzie for and on behalf of Monsanto Company |
3
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to China National Chemical Corporation acquiring shares and controlling interest in Syngenta A.G.
|
44 bln USD
|
Asters for and on behalf of China National Chemical Corporation and Syngenta A.G.
|
4
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine for acquisition of controlling interest in Huntsman Corporation by Clariant AG (Clariant Ltd)
|
about 20 bln USD
|
Asters for and on behalf of Clariant AG (Clariant Ltd) and Huntsman Corporation
|
5
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due for acquisition of Capsugel S.A by Lonza Group AG
|
5.5 bln USD
|
Baker McKenzie for and on behalf of Lonza Group AG. Asters for and on behalf of KKR |
6
|
Obtaining clearance from the Antimonopoly Committee of Ukraine for merger and coordinated actions due to acquisition of business of Wirtgen Group companies by Deere & Company
|
4.36 bln EUR
|
Asters for and on behalf of Deere & Company and Wirtgen Group Holding Gmbh
|
7
|
Obtaining clearance from the Antimonopoly Committee of Ukraine for acquisition of STADA by Cinven and Bain Capital
|
about 4.1 bln EUR
|
Sayenko Kharenko for and on behalf of Bain Capital Investors, L.L.C., Cinven Capital Management (VI) General Partner Limited and STADA Arzneimittel Aktiengesellschaft
|
8
|
Obtaining clearance from the Antimonopoly Committee of Ukraine for Maersk Line’s acquisition of sole control over HSDG
|
3.7 bln EUR
|
Sayenko Kharenko for and on behalf of Maersk Line A/S, Hamburg Südamerikanische Dampfschifffahrts-Gesellschaft KG, Dr. August Oetker KG
|
9
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition by Crédit Agricole S.A. (via Amundi S.A.) of shares in UniCredit Group companies
|
3.5 bln EUR
|
Asters for and on behalf of Crédit Agricole S.A. and UniCredit S.p.A.
|
10
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition of New NP shares by Électricité de France S.A.
|
about 2.5 bln EUR
|
Asters for and on behalf of Électricité de France S.A. and Areva NP
|
11
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition of (1) automotive business of Opel by Peugeot S.A., (2) joint control over the European financial companies of General Motors by Peugeot S.A. in cooperation with BNP Paribas S.A.
|
about 2.2 bln EUR
|
Asters for and on behalf of Peugeot S.A., General Motors Holdings LLC and BNP Paribas S.A.
|
12
|
Obtaining clearance from the Antimonopoly Committee of Ukraine for merger and coordinated actions due to acquisition of control over Lumileds Holdings B.V. at Philips Group using funds managed by Apollo Global Management L.P.
|
about 2 bln USD
|
Aequo for and on behalf of Apollo Global Management L.P. and Philips Group
|
13
|
Obtaining clearance from the Antimonopoly Committee of Ukraine for (1) acquisition of assets for production of insecticides, herbicides and activities on research and development of plant protection means by FMC, (2) acquisition of assets of Health and Food FMC division by DuPont
|
1.6 bln USD
|
Sayenko Kharenko for and on behalf of E.I. du Pont de Nemours and Company and FMC Corporation E. I. du Pont de Nemours and Company |
14
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition of E.ON Norwegian Mining Company by LetterOne Group
|
1.6 bln USD
|
Ilyashev & Partners for and on behalf of LetterOne
|
15
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition of Netafim, Ltd. by Mexichem Soluciones Integrales Holding, S.A. de C.V.
|
1.5 bln USD
|
Asters for and on behalf of Mexichem Soluciones Integrales Holding, S.A. de C.V. and Netafim, Ltd
|
16
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition of (1) control over Hitachi Kokusai Electric Inc. by Japan Industrial Partners, Inc., (2) shares in Hitachi Kokusai Electric Inc. by HKE Holdings G.K.
|
about 1.3 bln USD
|
Asters for and on behalf of Japan Industrial Partners, Inc., HKE Holdings G.K. and Hitachi, Ltd
|
17
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to acquisition by LKQ Corporation of Rhiagу
|
1.04 bln EUR
|
Aequo for and on behalf of Apax Partners, which acted as the seller in this transaction
|
18
|
Obtaining clearance from the Antimonopoly Committee of Ukraine for acquisition of shares of Samsung Electronics (Shandong) Digital Printing Co., Ltd, Simpress Comercio, Locacao e Servicos S.A., PrinterOn Inc., and S-Printing Solution Co., Ltd by HP Inc.
|
1.05 bln USD
|
Sayenko Kharenko for and on behalf of HP Inc., Samsung Electronics Co., Ltd
|
19
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to consolidation of affiliated Siemens Aktiengesellschaft with Gamesa Corporación Tecnológica, S.A.
|
about 1 bln USD
|
Asters for and on behalf of Gamesa Corporación Tecnológica, S.A. and Siemens Aktiengesellschaft
|
20
|
Obtaining merger clearance from the Antimonopoly Committee of Ukraine due to (1) acquisition of shares in Solvay Acetow GmbH, Newco FR, Newco BR, Newco SGP and Primester by Blackstone via BCP VII Jade Luxemburg Holdco S.à.r.l., (2) coordinated actions related to merging
|
about 1 bln USD
|
Asters for and on behalf of Blackstone and Solvay SA
|
NOTE: THE SPECIFIED TRANSACTIONS WERE MADE IN THE IV QUARTER OF 2016 – I-III QUARTERS OF 2017. TRANSACTIONS SPECIFIED ON A CONFIDENTIAL BASIS ARE NOT INCLUDED IN THE TABLE.